Literature DB >> 9731059

Ultrastructural analysis of bone marrow hematopoiesis in mice transgenic for the thymidine kinase gene driven by the alpha IIb promoter.

C Poujol1, D Tronik-Le Roux, P Tropel, V Roullot, A Nurden, G Marguerie, P Nurden.   

Abstract

Transgenic mice have been generated with expression of the herpes virus thymidine kinase gene directed by a 2.7-kb fragment of the alphaIIb murine promoter of the gene encoding the alphaIIb-subunit of the platelet integrin alphaIIbbeta3 (Tropel et al, Blood 90:2995, 1997). Administration of ganciclovir (GCV) to these mice resulted not only in an acute cessation of platelet production due to the depletion of the megakaryocytic lineage, but also a decrease in erythrocyte and leukocyte numbers. Immunogold staining on ultrathin frozen sections and electron microscopy has now shown that the remaining population of immature hematopoietic cells contain a high proportion of Sca-1(+) and CD34(+) cells, with CD45R+ cells of the lymphopoietic lineage being maintained. Stromal cells were also preserved. Blood thrombopoietin levels were high. At 4 days of the recovery phase, Sca-1 and CD34 antigen expression decreased with intense proliferation of cells of the three lineages, with megakaryocyte (MK) progenitors being identified by their positivity for glycoprotein IIb-IIIa. These results suggest that transcriptional activity for the alphaIIb gene promoter was present on pluripotent hematopoietic stem cells. At 6 to 8 days after cessation of GCV, numerous mature MK were observed, some of them with deformed shapes crossing the endothelial barrier through thin apertures. Proplatelet production was visualized in the vascular sinus. After 15 days, circulating platelet levels had increased to approximately 65% of normal. Transgenic alphaIIb-tk mice constitute a valuable model to study in vivo megakaryocytopoiesis. Copyright 1998 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9731059

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Increased thrombin responsiveness in platelets from mice lacking glycoprotein V.

Authors:  V Ramakrishnan; P S Reeves; F DeGuzman; U Deshpande; K Ministri-Madrid; R B DuBridge; D R Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

Review 2.  Platelets as delivery systems for disease treatments.

Authors:  Qizhen Shi; Robert R Montgomery
Journal:  Adv Drug Deliv Rev       Date:  2010-07-07       Impact factor: 15.470

3.  Identification of resident and inflammatory bone marrow derived cells in the sclera by bone marrow and haematopoietic stem cell transplantation.

Authors:  Toshio Hisatomi; Koh-hei Sonoda; Fumihiko Ishikawa; Hong Qiao; Takahiro Nakazawa; Mitsuhiro Fukata; Toru Nakamura; Kousuke Noda; Shinsuke Miyahara; Mine Harada; Shigeru Kinoshita; Ali Hafezi-Moghadam; Tatsuro Ishibashi; Joan W Miller
Journal:  Br J Ophthalmol       Date:  2006-10-11       Impact factor: 4.638

4.  Correlation of plasma FL expression with bone marrow irradiation dose.

Authors:  Mary Sproull; Dane Avondoglio; Tamalee Kramp; Uma Shankavaram; Kevin Camphausen
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

5.  A Novel Model of Intravital Platelet Imaging Using CD41-ZsGreen1 Transgenic Rats.

Authors:  Makoto Mizuno; Atsuyuki Tomizawa; Kousaku Ohno; Joseph A Jakubowski; Atsuhiro Sugidachi
Journal:  PLoS One       Date:  2016-04-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.